Refractory Angina clinical trials

Explore recruiting refractory angina clinical trials.

Recruiting refractory angina studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Angina trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (with 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety (EXACT-2 Trial)

Belgium, Poland, Hungary, Netherlands, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina. A phase II randomized, double-blinded, placebo-controlled study.

Denmark, Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Refractory Angina trials by city

Refractory Angina in Toronto Refractory Angina in Vancouver Refractory Angina in Montreal Refractory Angina in Calgary Refractory Angina in Edmonton Refractory Angina in Ottawa Refractory Angina in Winnipeg Refractory Angina in Quebec City Refractory Angina in Hamilton Refractory Angina in Kitchener Refractory Angina in London Refractory Angina in Halifax Refractory Angina in New York Refractory Angina in Los Angeles Refractory Angina in Chicago Refractory Angina in Houston

Refractory Angina clinical trials

Recruiting refractory angina studies right now

COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions

Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.

Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina

Also recruiting in Europe

Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (with 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety (EXACT-2 Trial)

Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina. A phase II randomized, double-blinded, placebo-controlled study.

Refractory Angina trials by city

Other conditions